InMode Ltd.

Good morning and welcome to the InMode Limited Second Quarter 2022 Earnings Results Conference Call. All participants will be in the listen-only mode. Should you need assistance, please sign up a conference specialist by pressing the Start key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press Start and 1 on your telephone keypad. To withdraw your questions, please press star then two. Please know this event is being recorded. I would now like to turn the conference over to Mary Segal, CEO of MSIR. Please go ahead.

Thank you, operator, and to everyone for joining us today. Welcome to INMO's second quarter 2022 earnings call. Before we begin, I would like to remind our listeners that certain information provided on this call may contain false booking statements, and the fake Harvard statement outlined in today's earnings release also pertains to this call. If you have not received a copy of the release, please visit the Investor Relations section of the company's website. Changes in business, competitive, technological, regulatory, and other factors could cause actual results to differ materially from those expressed by the forward-looking statements made today. Our historical results are not necessarily indicative of future performance. As such, we can give no assurance as to the accuracy of performance our forward-looking statements and assume no obligation to update them, except as required by law. With that, I'd like to turn the call over to Moshe Misrafi, Chairman and CEO. Moshe, please go ahead.

Thank you, Miri, and thanks to everyone joining us for our second quarter 2022 earning call. With me today, Dr. Michael Quindle, our Co-Founder and Chief Technology Officer, Yair Malka, our Chief Financial Officer, Shaquille Occhiani, our President in North America, Dr. Spiro Teodoro, our Chief Medical Officer, and Raphael Liekerman, our VP of Finance. Following our prepared remarks, we will all be available for a Q&A session. We are pleased to report another record quarter, with revenue of $113.5 million, an increase of 30% compared to the same period last year. Clearly, growth across the U.S. and the key regions globally underscore the strong demand for our technologies and our product portfolios. Our growth engine includes the launch of two new modalities every year, growth in the United States, geographical expansion outside the U.S., and high volume sales of consumables as a result of more frequent use of our platforms. All these factors remain on track and support continued successful execution in the second half of 2022 and beyond. Our focus remains on our bipolar RF technology, offering minimally invasive surgical platforms for the body, face, and also for women health. We have highly efficient sales team of more than 200 reps worldwide. With their excellent work, sales of capital equipment represent 87% of our total revenue in the second quarter. While sales of consumable and services accounted for the remaining 13%. We're excited to see the numbers of consumable sales growing quarter after quarter and consistently hitting new highs. As our install rates grow and we expand our market share, consumable and services will contribute a bigger portion to our revenue mix. Moving to our international operation, second quarter sales outside the U.S., accounted for $41.2 million, or 36% of sales, a 33% increase compared to Q2 last year. InMode denials operate in a total of 78 countries. Our newly opened subsidiary in Italy is up and running smoothly and contributing to our positive results in the European market. We see demand from Europe, Asia, and Latin America continuing to be strong. In addition, important markets such as China, Korea, Brazil, and Mexico gained traction thanks to the effort of our local presence. On the macro level, supply chain issues during the quarter were under control and closely managed as we continue to prioritize maintaining sufficient inventory levels. placing order ahead of time and making exceptional effort to hold delivery time around the 10 days mark. Now, I would like to turn the call over to Shaquille, our president in North America. Shaquille.